You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1337 The preclinical characterization and translational research of ATG-031, a first-in-class humanized anti-CD24 antibody, for the treatment of solid tumors and hematological malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1337 The preclinical characterization and translational research of ATG-031, a first-in-class humanized anti-CD24 antibody, for the treatment of solid tumors and hematological malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023174020
Dec 202348014
Jan 20244104
Feb 20246807
Mar 202448012
Apr 202452028
May 20243804
Jun 20249507
Jul 202450011
Aug 202446015
Sep 20243805
Oct 202456015
Nov 202441016
Dec 202436017
Jan 202524011
Feb 202510013
Mar 20250010
Apr 2025108
May 20250012
Jun 2025108
Total8670237